Hostname: page-component-74656f9884-8r8nv Total loading time: 0 Render date: 2026-11-08T10:23:24.429Z Has data issue: false hasContentIssue false

INECO Frontal Screening (IFS): A brief, sensitive, and specific tool to assess executive functions in dementia–CORRECTED VERSION

Published online by Cambridge University Press:  28 July 2009

TERESA TORRALVA*
Affiliation:
Institute of Cognitive Neurology (INECO), Buenos Aires, Argentina Institute of Neurosciences Favaloro University, Buenos Aires, Argentina
MARÍA ROCA
Affiliation:
Institute of Cognitive Neurology (INECO), Buenos Aires, Argentina Institute of Neurosciences Favaloro University, Buenos Aires, Argentina
EZEQUIEL GLEICHGERRCHT
Affiliation:
Institute of Cognitive Neurology (INECO), Buenos Aires, Argentina
PABLO LÓPEZ
Affiliation:
Institute of Cognitive Neurology (INECO), Buenos Aires, Argentina Institute of Neurosciences Favaloro University, Buenos Aires, Argentina
FACUNDO MANES
Affiliation:
Institute of Cognitive Neurology (INECO), Buenos Aires, Argentina Institute of Neurosciences Favaloro University, Buenos Aires, Argentina
*
*Correspondence and reprint requests to: Teresa Torralva, Instituto de Neurología Cognitiva (INECO), Castex 3293 (1425), Buenos Aires, Argentina. E-mail: ttorralva@neurologiacognitiva.org
Rights & Permissions [Opens in a new window]

Abstract

Although several brief sensitive screening tools are available to detect cognitive dysfunction, few have been developed to quickly assess executive functioning (EF) per se. We designed a new brief tool to evaluate EF in neurodegenerative diseases. Patients with an established diagnosis of behavioral variant frontotemporal dementia (bvFTD; n = 22), Alzheimer disease (AD; n = 25), and controls (n = 26) were assessed with a cognitive screening test, the INECO Frontal Screening (IFS), and EF tests. Clinical Dementia Rating Scale (CDR) scores were obtained for all patients. Internal consistency of the IFS was very good (Cronbach’s alpha = .80). IFS total (out of 30 points) was 27.4 (SD = 1.6) for controls, 15.6 (SD = 4.2) for bvFTD, and 20.1 (SD = 4.7) for AD. Using a cutoff of 25 points, sensitivity of the IFS was 96.2%, and specificity 91.5% in differentiating controls from patients with dementia. The IFS correlated significantly with the CDR and executive tasks. The IFS total discriminated controls from demented patients, and bvFTD from AD. IFS is a brief, sensitive, and specific tool for the detection of executive dysfunction associated with neurodegenerative diseases. The IFS may be helpful in the differential diagnosis of FTD and AD. (JINS, 2009, 15, 777–786.)

Information

Type
Research Articles
Copyright
Copyright © The International Neuropsychological Society 2009
Figure 0

Table 1. Subtests grouped into the different executive functions tapped by the IFS

Figure 1

Table 2. Demographic and general cognitive status information

Figure 2

Fig. 1. Mean (SD) scores for Controls, Alzheimer’s disease (AD), and behavioral variant frontotemporal dementia (bvFTD) groups on the INECO Frontal Screening (IFS).

Figure 3

Table 3. Inter-subscale correlation matrix

Figure 4

Fig. 2. Correlations between the INECO Frontal Screening (IFS) total score and the Mini Mental State Examination (MMSE), the Addenbrooke’s Cognitive Examination (ACE) total score, phonological fluency task, latency to complete Trail Making Test-Part B (TMT-B), and Wisconsin Card Sorting Test (WCST, categories and perseverations). Data points represent behavioral variant frontotemporal dementia (bvFTD, ●), Alzheimer’s disease (AD, ■), and controls (▲). Linear fit lines are presented with mean confidence intervals.

Figure 5

Fig. 3. Mean (SD) scores for Alzheimer’s disease (AD) and behavioral variant frontotemporal dementia (bvFTD) groups on each subtests of the INECO Frontal Screening (IFS). *p < .05, ***p < .001.

Figure 6

Fig. 4. Receiver operating characteristic (ROC) curve analyses for dementia versus controls (left) and between dementia groups (right).